CTLA4 and neoplasm: Although elimination of CTLA-4 can result in several diseases including autoimmune diseases, effective anti-tumor immunity sometimes requires the blockade of CTLA-4 (Brunner-Weinzierl and Rudd, 2018; Hosseini et al., 2020).